Morpholine → HCID 66878419, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[N+:7]([C:10]1[CH:15]=[CH:14][C:13]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[N:27]=[CH:26][C:25]([CH:28]=O)=[CH:24][CH:23]=3)[CH2:18][CH2:17]2)=[CH:12][CH:11]=1)([O-:9])=[O:8].C([BH3-])#N.[Na+]>O1CCCC1.C(O)(=O)C.C(Cl)(Cl)Cl>[N+:7]([C:10]1[CH:15]=[CH:14][C:13]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[N:27]=[CH:26][C:25]([CH2:28][N:1]4[CH2:6][CH2:5][O:4][CH2:3][CH2:2]4)=[CH:24][CH:23]=3)[CH2:18][CH2:17]2)=[CH:12][CH:11]=1)([O-:9])=[O:8]Participants
Procedure
Morpholine (250 mg, 2.87 mmol) was added to a suspension of 6-[4-(4-nitrophenyl)piperazin-1-yl]pyridine-3-carbaldehyde (750 mg, 2.41 mmol) and sodium cyanoborohydride (454 mg, 7.23 mmol) in a mixture of tetrahydrofuran (10 mL) and acetic acid (0.5 mL) at ambient temperature then heated at reflux for 3 h. The mixture was then concentrated in vacuo to give a gummy solid which was dissolved in chloroform (40 mL), washed with water (2×20 mL), brine (2×15 mL), dried over anhydrous sodium sulfate and concentrated in vacuo to give the crude compound. Purification by column chromatography over neutral alumina using 20-30% of ethyl acetate in petroleum ether afforded 4-[[6-[4-(4-nitrophenyl)piperazin-1-yl]-3-pyridyl]methyl]morpholine (550 mg, 59%).
Workup
- temperaturethen heated
- temperatureat reflux for 3 h
- concentrationThe mixture was then concentrated in vacuo
- customto give a gummy solid which
- washwashed with water (2×20 mL), brine (2×15 mL)
- dry with materialdried over anhydrous sodium sulfate
- concentrationconcentrated in vacuo
- customto give the crude compound
- customPurification by column chromatography over neutral alumina using 20-30% of ethyl acetate in petroleum ether
Sources & evidence
- ORD record
- ord-db2c137367ef46f4b749dff09657171a
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08993574B2
Reaction notes
Loading…